Grifols Launches a New Testing Service for Patients Treated with Daratumumab

Grifols Launches a New Testing Service for Patients Treated with Daratumumab

May 31, 2018 – The Daratumumab neutralization testing service from Grifols, will allow improved management of patients under Daratumumab treatment requiring transfusion – Test will be offered at Grifols Immunohematology Center in San Marcos, Texas BARCELONA, Spain, May 31, 2018 /PRNewswire/ — Grifols